Tevogen (TVGN) Long-Term Investments (2021 - 2023)

Tevogen Bio Holdings (TVGN) has 3 years of Long-Term Investments data on file, last reported at $16.7 million in Q4 2023.

• Quarterly Long-Term Investments fell 95.32% year-over-year to $16.7 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $16.7 million (down 95.32% YoY) and the FY2023 annual result came in at $16.7 million, down 95.32% from the prior year.
• Long-Term Investments slipped to $16.7 million in Q4 2023, from $26.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $356.9 million in Q4 2022 to a low of $16.7 million in Q4 2023.
• A 3-year average of $206.8 million and a median of $351.9 million in 2021 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2022 — Long-Term Investments gained 1.41% — and 2023, when it tumbled 95.32%.
• Tracing TVGN's Long-Term Investments over 3 years: stood at $351.9 million in 2021, then increased by 1.41% to $356.9 million in 2022, then plunged by 95.32% to $16.7 million in 2023.
• The last three Long-Term Investments figures came in at $16.7 million (Q4 2023), $26.0 million (Q3 2023), and $25.7 million (Q2 2023), per Business Quant data.